Alternatively, the presence of TGFβ in both the periphery as well as the tumor of αPD-L1-treated animals may prevent CD8+ T cell activation upon vaccination, which M7824 can overcome as it both sequesters plasma TGFβ1 and prevents TGFβ-induced signaling. Here, CD8A is linked to neoplasm.